4SC AG - Product Pipeline Review - 2014
Global Markets Direct's, '4SC AG - Product Pipeline Review - 2014', provides an overview of the 4SC AG's pharmaceutical research and development focus.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
• The report provides brief overview of 4SC AG including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of 4SC AG's human therapeutic division and enlists all their major and minor projects
• The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
For more Information About 4SC AG - Product Pipeline Review - 2014 Click:
http://www.radiantinsights.com/research/4sc-ag-product-pipeline-review-2014
ActogeniX NV - Product Pipeline Review - 2014
Global Markets Direct's, 'ActogeniX NV - Product Pipeline Review - 2014', provides an overview of the ActogeniX NV's pharmaceutical research and development focus.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
• The report provides brief overview of ActogeniX NV including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of ActogeniX NV's human therapeutic division and enlists all their major and minor projects
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest company statement
• Latest news and deals relating to the ActogeniX NV's pipeline products
For more Information About ActogeniX NV - Product Pipeline Review – 2014 Click:
http://www.radiantinsights.com/research/actogenix-nv-product-pipeline-review-2014
Ablynx NV - Product Pipeline Review - 2014
Global Markets Direct's, 'Ablynx NV - Product Pipeline Review - 2014', provides an overview of the Ablynx NV's pharmaceutical research and development focus.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Scope
• The report provides brief overview of Ablynx NV including business description, key information and facts, and its locations and subsidiaries
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest company statement
• Latest news and deals relating to the Ablynx NV's pipeline products
For more Information About Ablynx NV - Product Pipeline Review - 2014 Click:
http://www.radiantinsights.com/research/ablynx-nv-product-pipeline-review-2014
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For more information, visit: http://www.radiantinsights.com/
Blog URL: http://www.terrapass.org/
Media ContactCompany Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist - USA
Email:Send Email
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/4sc-ag-product-pipeline-review-2014
